State of New Jersey Common Pension Fund D Has $1.53 Million Holdings in Progyny, Inc. (NASDAQ:PGNY)

State of New Jersey Common Pension Fund D grew its holdings in shares of Progyny, Inc. (NASDAQ:PGNY) by 29.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 91,409 shares of the company’s stock after acquiring an additional 20,692 shares during the quarter. State of New Jersey Common Pension Fund D owned 0.10% of Progyny worth $1,532,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Quarry LP increased its position in Progyny by 1,900.0% during the 2nd quarter. Quarry LP now owns 880 shares of the company’s stock worth $25,000 after purchasing an additional 836 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Progyny during the 2nd quarter valued at $44,000. Cambridge Trust Co. bought a new stake in Progyny during the 1st quarter worth $95,000. Natixis Investment Managers International bought a new stake in Progyny during the 1st quarter worth $117,000. Finally, Mendota Financial Group LLC acquired a new position in Progyny in the 3rd quarter worth about $56,000. Institutional investors own 94.93% of the company’s stock.

Progyny Stock Up 0.9 %

Progyny stock opened at $13.90 on Tuesday. The company has a market capitalization of $1.18 billion, a PE ratio of 23.97, a PEG ratio of 1.44 and a beta of 1.44. The firm’s fifty day moving average is $17.11 and its 200 day moving average is $23.11. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $42.08.

Progyny (NASDAQ:PGNY) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The company had revenue of $286.63 million for the quarter, compared to the consensus estimate of $296.85 million. Progyny had a return on equity of 11.36% and a net margin of 5.03%. Progyny’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same period last year, the company earned $0.16 EPS. Sell-side analysts expect that Progyny, Inc. will post 0.64 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Cantor Fitzgerald restated an “overweight” rating and set a $25.00 price target on shares of Progyny in a report on Tuesday, October 1st. JMP Securities downgraded shares of Progyny from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 19th. Barclays reduced their price objective on shares of Progyny from $30.00 to $17.00 and set an “overweight” rating on the stock in a research note on Thursday, November 14th. BTIG Research lowered Progyny from a “buy” rating to a “neutral” rating in a research report on Wednesday, August 7th. Finally, Leerink Partnrs lowered Progyny from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 7th. Eight research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Progyny has a consensus rating of “Hold” and an average price target of $25.42.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.